Designing Clinical Trials for Diversity, Inclusion & Representativeness

Sep 30, 2025 | Inside the Trends

How can clinical research move from talking about diversity to embedding representativeness as a foundation of trial design? In this episode of The Future Prescription: Inside the Trends, industry leaders explore how equitable design can transform science, improve...

TriNetX Named Among the Top 25 Healthcare Software Companies of 2025

Sep 29, 2025 | Press Releases

Recognition by The Healthcare Technology Report underscores TriNetX’s innovation in real-world data, artificial intelligence, and clinical research transformation.    CAMBRIDGE Mass., September 25, 2025 — TriNetX, the company behind the world’s broadest federated...

Putting Patients First: A Conversation with Ora on the Future of Clinical Trials

Sep 22, 2025 | Blog

In my role at TriNetX, I have the privilege of engaging with leaders across the clinical research landscape who are challenging the status quo and pushing us toward a more inclusive, tech-enabled, and patient-first future. One of the most rewarding conversations I’ve...

Care Reimagined: The Shift Toward Patient-Centric Research

Sep 12, 2025 | Inside the Trends

What happens when clinical research is redesigned around the needs, preferences, and lives of real people? In this episode of The Future Prescription: Inside the Trends, discover how sponsors and CROs are aligning clinical and commercial priorities to create smarter,...

Inclusion Is the New Standard: Biopharma’s Push for More Representative Clinical Trials

Sep 8, 2025 | Blog

As clinical trials evolve, one thing is certain: representativeness is no longer a nice-to-have; it’s a non-negotiable. The data are clear. In the 2025 TriNetX and studioID survey of 150 senior biopharma executives, 84% reported ramping up efforts to improve...

ISPE to Impact: Shaping the Next Era of Pharmacoepidemiology with Real-World Data

Sep 2, 2025 | Blog

Reflecting on the discussions from this year’s International Society for Pharmacoepidemiology (ISPE) Annual Meeting and looking ahead to the future of the field, I’m struck by the steady but significant evolution pharmacoepidemiology is undergoing driven in large part...

From Buzz to Breakthrough: How Biopharma Is Embedding Real-World Data into Drug Development

Aug 4, 2025 | Blog

In just a few years, real-world data (RWD) has evolved from an industry buzzword to a core driver of progress in drug development. What used to be experimental is now operational and increasingly essential. In the 2025 TriNetX and studioID survey of 150 senior...

New TriNetX Research Impact Report Illuminates How Real-World Data is Fueling Rare Disease Innovation

Jul 31, 2025 | Press Releases

Analysis reveals strategic opportunities for pharmaceutical leaders to close treatment gaps and accelerate breakthroughs in underserved rare disease communities. Cambridge, MA, July 31, 2025 — TriNetX, driven by its vision of a connected world where data and...

Elevating Research and Patient Care: How HCOR – Associação Beneficente Síria is Advancing Innovation Through Real-World Data

Jul 28, 2025 | Network Spotlight

In an era where real-world data (RWD) is rapidly transforming clinical research, one organization is harnessing this potential to shape the future of healthcare in Brazil and beyond. HCOR – Associação Beneficente Síria, a renowned healthcare institution based in São...

New TriNetX Survey Reveals Biopharma’s Bold Embrace of Real-World Data and Artificial Intelligence—But Warns of Looming Barriers

Jul 10, 2025 | Press Releases

Real-world data (RWD), artificial intelligence (AI), and patient-centric trial design lead pharma priorities in 2025, but data compatibility, regulatory hurdles, and security concerns threaten to stall momentum.   CAMBRIDGE, MA – July 10, 2025 – As...